Molecular Characteristics of Phlegm-heat Syndrome in Ischemic Stroke

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

June 20, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Ischemic Stroke, Acute

Interventions

DRUG

Guideline-based treatment

Guideline-based treatment includes anti-platelet therapy, control of vascular risk factors, and so on.

Trial Locations (1)

Dongzhimen Hospital, Beijing

All Listed Sponsors

lead

Dongzhimen Hospital, Beijing

OTHER

NCT06470477 - Molecular Characteristics of Phlegm-heat Syndrome in Ischemic Stroke | Biotech Hunter | Biotech Hunter